Nordhealth AS (OSL:NORDH)
36.60
0.00 (0.00%)
Aug 22, 2025, 2:55 PM CET
Nordhealth AS Revenue
Nordhealth AS had revenue of 12.86M EUR in the quarter ending June 30, 2025, with 5.37% growth. This brings the company's revenue in the last twelve months to 48.67M, up 17.78% year-over-year. In the year 2024, Nordhealth AS had annual revenue of 45.68M with 24.03% growth.
Revenue (ttm)
48.67M EUR
Revenue Growth
+17.78%
P/S Ratio
5.01
Revenue / Employee
118.41K EUR
Employees
411
Market Cap
2.90B NOK
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 45.68M | 8.85M | 24.03% |
Dec 31, 2023 | 36.83M | 5.78M | 18.60% |
Dec 31, 2022 | 31.05M | 10.75M | 52.96% |
Dec 31, 2021 | 20.30M | 7.62M | 60.04% |
Dec 31, 2020 | 12.68M | 5.04M | 66.02% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 628.08M |
Photocure ASA | 522.86M |
ArcticZymes Technologies ASA | 104.33M |
Vistin Pharma ASA | 452.25M |
Omda AS | 442.14M |
Gentian Diagnostics ASA | 163.38M |
Lytix Biopharma AS | 608.00K |
Nykode Therapeutics AS | 87.09M |